Cobalt Toxicity: Heart (Cardiomyopathy)
When the body is flooded with too much cobalt, one of the organs that can fail is the heart: the muscle of the heart weakens and stretches into a poorly pumping bag — a condition called cardiomyopathy — and the result is heart failure, with breathlessness, swelling, and exhaustion. This is a real and well-documented form of poisoning, made famous by an epidemic of dying beer drinkers in the 1960s and revived in recent years by a small number of patients with failing metal hip implants. But it must be put in honest perspective: cobalt cardiomyopathy is rare, it essentially never comes from food or ordinary vitamin B12, and the symptoms it causes — breathlessness, swelling, fatigue — are far more often due to something else entirely. This page explains how cobalt damages the heart, what it feels like, why these symptoms are not proof of cobalt at all, and the specific clues that point doctors toward this uncommon cause.
Table of Contents
- What Cobalt Cardiomyopathy Feels Like
- The Mechanism: How Cobalt Poisons the Heart Muscle
- An Honest Caveat: These Symptoms Have Many Causes
- Clues That Point Toward Cobalt
- Where the Cobalt Comes From
- Getting Checked
- How Cobalt Cardiomyopathy Is Treated
- Red Flags: Signs Hospitals Treat as Urgent
- Key Research Papers
- Connections
- Featured Videos
What Cobalt Cardiomyopathy Feels Like
Cobalt cardiomyopathy is a dilated cardiomyopathy: the heart muscle becomes weak and floppy, the main pumping chamber (the left ventricle) stretches and balloons outward, and with each beat it ejects a smaller and smaller fraction of the blood inside it. The body responds to a failing pump exactly as it would to heart failure from any other cause, so the symptoms are the symptoms of heart failure:
- Breathlessness. At first only on exertion — climbing stairs, walking uphill, carrying groceries — then with less and less effort. A telling feature is orthopnea: becoming short of breath when lying flat, so that you need to prop yourself up on extra pillows, and sometimes waking suddenly at night gasping for air.
- Swelling (edema). Fluid backs up and pools in the lowest parts of the body, so the ankles, feet, and lower legs swell, the socks leave deep marks, and the abdomen may bloat. The weight can climb several pounds in a few days purely from retained fluid.
- Fatigue and weakness. A heart that pumps poorly delivers less blood to the muscles and brain, leaving a person drained, foggy, and unable to do what they used to.
- Palpitations and a fast or irregular pulse. A stretched, struggling heart is prone to abnormal rhythms, so a racing, pounding, or skipping heartbeat is common — see also arrhythmia and heart palpitations.
- A poor appetite, nausea, and unintended weight loss as fluid congests the liver and gut — a state doctors call cardiac cachexia in its advanced form.
What makes the historical cobalt cases so striking is how fast and severe they could be. In the 1960s beer-drinkers' epidemic, previously well people went from feeling fine to profound heart failure over days to a few weeks, and many died quickly — a far more abrupt and lethal course than the gradual decline of most ordinary heart failure. The cobalt cases linked to metal hip implants have tended to come on more slowly, over months, often tangled up with other symptoms of cobalt poisoning such as hearing loss, visual changes, thyroid problems, or nerve symptoms (those whole-body effects, and the exposure routes, are covered on the companion page, Cobalt Toxicity: Metal Implants & Inhalation).
The Mechanism: How Cobalt Poisons the Heart Muscle
The heart is the most energy-hungry muscle in the body. It never rests, and to keep beating it relies almost entirely on aerobic metabolism — burning fuel with oxygen inside its cells' mitochondria, the tiny power plants that turn food into usable energy. Anything that sabotages those power plants hits the heart harder than almost any other organ, and that is precisely what excess cobalt does.
Cobalt interferes with a key step in cellular energy production. To burn fuel for energy, cells must feed two-carbon fragments (as acetyl groups) into the mitochondria's central furnace, the citric acid cycle. Cobalt binds to and disables the enzyme machinery that prepares that fuel — in particular it ties up lipoic acid, a sulfur-containing helper molecule that the key gatekeeping enzymes need to work. With the gate jammed, fuel piles up uselessly outside the furnace, the mitochondria cannot make enough energy, and the perpetually working heart muscle, starved of power, begins to weaken, stretch, and die off cell by cell. Under the microscope, pathologists found exactly this: swollen, damaged mitochondria and dying muscle fibers throughout the hearts of the beer drinkers.
An analogy. Picture the heart as a delivery truck that must run twenty-four hours a day and is filled with diesel. Cobalt does not slash the fuel line — the tank stays full — it quietly clogs the fuel injectors, the part that feeds fuel into the engine. The gauge still reads full, but the engine sputters and stalls because it can't actually use what's in the tank. A muscle that can rest, like a leg, can coast on a stalling engine for a while; a heart that can never stop simply runs itself into the ground.
Two further details explain why some people poisoned by cobalt got cardiomyopathy and others did not. First, this is a dose problem: a large, sustained cobalt load is needed — a brief or modest exposure does not damage the heart. Second, the beer epidemic showed that cobalt's toxicity is amplified by other stresses. The heaviest drinkers, who were also often poorly nourished, low in protein, and depleted of thiamine (vitamin B1, itself essential for the very same energy step), were the ones who collapsed. Alcohol's own toxic effect on heart muscle stacked on top of the cobalt. The cobalt was the trigger, but a malnourished, alcohol-soaked, thiamine-poor body was the tinder — which is part of why the same beer additive caused an epidemic of heart failure in heavy drinkers and almost nothing in the general public. A 2016 reappraisal names the cofactors that cobalt cardiomyopathy seems to require as a low-protein diet, thiamine deficiency, alcoholism and hypothyroidism — PubMed PMID: 27852654.
An Honest Caveat: These Symptoms Have Many Causes
This is the most important section to read before worrying that your own breathlessness or swollen ankles mean cobalt poisoning. They almost certainly do not. Breathlessness, leg swelling, fatigue, and palpitations are among the most common symptoms in all of medicine, and dilated cardiomyopathy — the specific weak-heart picture cobalt produces — has a long list of far more frequent causes. Cobalt is a genuinely rare one.
Dilated cardiomyopathy and heart failure are usually caused by things like:
- Coronary artery disease — previous or ongoing damage from blocked heart arteries (the single most common cause of a weak heart).
- Long-standing high blood pressure, which wears the heart muscle out over years.
- Heavy alcohol use, which directly poisons heart muscle (alcoholic cardiomyopathy) — relevant here because it can look identical to, and historically overlapped with, the cobalt cases.
- Viral infections of the heart (viral myocarditis), pregnancy (peripartum cardiomyopathy), and inherited (genetic) cardiomyopathies that run in families.
- Thyroid disease, certain chemotherapy drugs, and other metabolic or autoimmune conditions.
And the everyday symptoms cobalt produces are even less specific. Breathlessness is far more often asthma, lung disease, anemia, anxiety, or simply being out of shape. Swollen ankles are commonly from venous problems, kidney or liver disease, prolonged sitting, or a medication side effect. Fatigue may be poor sleep, depression, thyroid trouble, anemia, or a hundred other things. None of these symptoms, alone or together, is evidence of cobalt. They are reasons the heart gets checked — and only then, in the right context, does cobalt enter the conversation. The honest bottom line: symptoms alone cannot identify cobalt poisoning; diagnosis rests on the picture below — an actual exposure, a confirmed weak heart and a blood cobalt level.
Clues That Point Toward Cobalt
Out of that long list of causes, cobalt comes into view in a specific setting. The diagnosis is almost always made not from the heart symptoms themselves but from the company they keep — the setting and the accompanying clues. Cobalt becomes a real consideration when:
- There is a clear, heavy cobalt exposure. The overwhelming modern cause is a failing metal-on-metal hip (or other) implant that is shedding cobalt as it wears. New or worsening heart failure in someone with a metal joint replacement — especially one that is painful, noisy, or known to be wearing — is the classic modern setup. Other exposures are heavy occupational exposure (the hard-metal industry) and, historically, contaminated beer.
- The heart failure has no obvious explanation. Cobalt rises to the top of the list mainly when the common causes — blocked arteries, high blood pressure, alcohol, a virus, a clear genetic pattern — have been looked for and not found. An unexplained dilated cardiomyopathy in someone with a metal implant is the combination that prompts a cobalt level.
- The heart failure follows a distinctive pattern. A 2016 reappraisal describes patients presenting with the subacute onset of severe heart failure, accompanied by low blood pressure (hypotension) and bluish skin (cyanosis), fluid around the heart (pericardial effusion), low voltage on the electrocardiogram, marked elevation of serum enzymes, and lactic acidosis, typically after months of lethargy, loss of appetite (anorexia) and weight loss. It names rapid-onset cardiomyopathy with polycythemia, pericardial effusion or goiter as the picture that calls for evaluation for cobalt exposure — PubMed PMID: 27852654.
- Other organs are failing at the same time. Systemic cobalt poisoning rarely attacks the heart alone. Telltale companions include hearing loss and ringing in the ears, vision changes, an underactive thyroid with a goiter (see hypothyroidism), nerve symptoms (numbness, tingling, weakness), skin rashes, and sometimes a thickened blood from over-production of red cells (polycythemia). When heart failure arrives alongside several of these, a toxic cause like cobalt becomes far more plausible than coincidence. The full systemic picture and its exposure routes are detailed on Cobalt Toxicity: Metal Implants & Inhalation.
Notice the pattern: it is never the breathlessness on its own. It is breathlessness plus a metal implant, plus a heart whose weakness is otherwise unexplained, plus, often, ringing ears or a failing thyroid. That cluster is the clue — and it is uncommon enough that most cardiologists may see it only once or twice in a career.
Where the Cobalt Comes From
Understanding the sources matters because it explains both why this poisoning is rare and why you cannot get it from your diet. The cobalt that damages hearts is always inorganic cobalt — the metal or its salts — absorbed in large amounts, which is biologically completely different from the trace of cobalt locked inside vitamin B12 in food. You cannot poison your heart by eating cobalt-containing foods or by taking ordinary B12.
- Worn metal joint implants (the modern cause). Some hip replacements used a metal-on-metal bearing made from a cobalt-chromium alloy. When such a joint wears abnormally, microscopic metal debris is released, dissolves, and raises blood cobalt — sometimes to hundreds of times normal. Most people with these implants never develop toxicity, but a minority with badly wearing devices have, and a small number of those have developed cobalt cardiomyopathy. This is now the leading route to a poisoned heart.
- A broken ceramic hip replaced with a metal part. A 2026 systematic review of more than 30 published cases described cobalt toxicity in people whose ceramic hip bearing fractured and was revised to a metal-on-polyethylene (metal-on-plastic) implant. Patients in this subgroup often had earlier symptom onset and elevated cobalt ion levels, and most presented with cardiovascular problems (cardiomyopathy, cardiogenic shock and heart failure), along with visual impairment, sensorineural hearing loss, cognitive impairment and thyroid dysfunction — PubMed PMID: 41550849.
- Contaminated beer (the historical cause). In the mid-1960s, several breweries in Quebec, Minnesota, Nebraska, and Belgium added small amounts of a cobalt salt to stabilize beer foam. Heavy drinkers consuming many liters a day took in a large daily cobalt dose, and clusters of severe, often fatal heart failure followed. Once cobalt was identified and banned from beer, the epidemic vanished — a closed chapter, but the source of nearly everything we know.
- Occupational and industrial exposure. Workers in the hard-metal (tungsten carbide) industry, and others who grind, machine, or are heavily exposed to cobalt dust, can absorb enough to cause systemic toxicity. The lungs are usually affected first, but the heart can be involved in severe cases.
- Misguided high-dose cobalt supplements. Inorganic cobalt was once used as a drug to treat anemia (it stimulates red-cell production) and is still sold by some sellers as a supposed “energy” or athletic aid. Inorganic cobalt salts taken in milligram doses are the kind of exposure behind the poisoning described here; the 2016 reappraisal ties the decline of cobalt cardiomyopathy to the waning medicinal use of cobalt and to reduced industrial exposure — PubMed PMID: 27852654.
The common thread is a large, sustained dose of inorganic cobalt over weeks to years. Brief or trace exposures — and all dietary cobalt — do not cause cardiomyopathy.
Getting Checked
Diagnosing cobalt cardiomyopathy is really two separate questions answered together: is the heart muscle weak? and is there too much cobalt to blame? Neither answer alone is enough.
First, the heart is assessed like any suspected heart failure. An echocardiogram (an ultrasound of the heart) is the central test: it shows the enlarged, poorly contracting left ventricle and measures the ejection fraction (the percentage of blood pumped out per beat), which is reduced in dilated cardiomyopathy. An electrocardiogram (ECG) records the rhythm, and a blood test for B-type natriuretic peptide (BNP) or N-terminal pro-B-type natriuretic peptide (NT-proBNP) — hormones the stretched heart releases — confirms the heart is under strain. A cardiac magnetic resonance imaging (MRI) can characterize the muscle in more detail and help look for other causes. Crucially, doctors also rule out the common culprits — checking the coronary arteries, blood pressure history, thyroid, and alcohol use — because cobalt is a diagnosis of the unexplained case.
Second, the cobalt level is measured directly. A simple blood (serum or whole-blood) cobalt test is the key step; a markedly elevated level in the right clinical setting is what links the metal to the heart. A urine cobalt level can support the picture. One honest caution: blood cobalt does not map perfectly onto heart damage — serum levels are not reliably predictive of clinical cardiotoxicity (PubMed PMID: 27852654), some people tolerate high levels, and interpreting the number requires expertise — which is exactly why the level is read alongside the exposure history and the confirmed cardiomyopathy, never in isolation. If an implant is suspected, imaging of the joint and orthopedic assessment follow. General blood work such as a Comprehensive Metabolic Panel and a Complete Blood Count rounds out the evaluation and can reveal the polycythemia or thyroid clues that point toward cobalt.
A 2026 systematic review of 18 published cases of cobalt-induced cardiomyopathy in people with metal-on-metal implants reported that diagnostic confirmation required serum cobalt levels typically exceeding 30-100 µg/L, with cardiac MRI showing non-ischemic fibrosis and oedema — scarring and swelling of the heart muscle not caused by blocked arteries — PubMed PMID: 41622383.
How Cobalt Cardiomyopathy Is Treated
Treatment rests on a principle that sets toxic cardiomyopathy apart from most heart failure: find and stop the source of the cobalt. Unlike, say, heart failure from old artery damage, this is a poisoning — and removing the poison can let the heart recover, sometimes substantially, if the damage is caught before it becomes permanent.
- Removing the source. This is the decisive step. For a worn metal-on-metal implant, that usually means surgically replacing (revising) the joint to stop the shedding of cobalt. For occupational exposure it means leaving the exposure. For the long-gone beer cause, it meant banning the additive. Once the source is removed, blood cobalt falls over weeks to months.
- Standard heart-failure therapy. While the body clears the cobalt, the failing heart is supported with the same proven medications used for any dilated cardiomyopathy — drugs that unload and protect the heart (such as angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers (ARBs), beta-blockers, and mineralocorticoid-receptor antagonists) and diuretics to drive off the retained fluid that causes the breathlessness and swelling. Rhythm problems are treated as needed. A newer class, sodium-glucose co-transporter 2 (SGLT2) inhibitors, was tested in heart failure generally rather than in cobalt cases: in a 2022 meta-analysis of five trials (21 947 participants), SGLT2 inhibitors reduced the risk of cardiovascular death or hospitalisation for heart failure (hazard ratio 0.77, 95% CI 0.72-0.82) and all-cause mortality (0.92, 0.86-0.99) — PubMed PMID: 36041474.
- Correcting what amplified the damage. Because deficiencies of thiamine and protein worsened the historical cases, attention to nutrition and to stopping alcohol matters, particularly when those factors are present.
- Chelation — a limited, specialist option. Drugs that bind metals (chelating agents) have been tried to speed cobalt removal, but the evidence is limited and they are not a routine or guaranteed fix; the mainstay remains removing the source. In a 2026 review of 18 implant cases, chelation therapy reduced cobalt burden but was rarely effective alone, while revision of the implant consistently led to clinical improvement when performed early, and delayed intervention was associated with irreversible heart-muscle damage and poorer outcomes — PubMed PMID: 41622383.
The outlook depends heavily on timing. The 1960s beer cases were often fatal because the diagnosis was unknown and the exposure continued. Modern implant cases caught reasonably early, with the source removed, have in a number of reports shown meaningful — sometimes near-complete — recovery of heart function. The 2016 reappraisal states that those who survive and cease exposure generally demonstrate complete resolution of symptoms and recovery of cardiac function — PubMed PMID: 27852654. In the most advanced cases, where the muscle is irreversibly destroyed, heart transplantation has been required. The lesson is the same throughout the literature: the sooner the cobalt is identified and stopped, the better the heart's chance.
Red Flags: Signs Hospitals Treat as Urgent
Cobalt cardiomyopathy is rare, but heart failure from any cause is serious, and these are the symptoms clinics treat as needing prompt assessment. A metal implant or other cobalt exposure is part of the history that matters for them:
- New or worsening breathlessness — especially shortness of breath when lying flat, needing extra pillows to sleep, or waking at night gasping for air.
- New swelling of the ankles, legs, or abdomen, or a rapid weight gain of several pounds over a few days from fluid.
- Unusual fatigue or reduced exercise tolerance — a marked drop in what you can do without getting winded.
- A metal hip or joint implant plus any of the above, or plus new hearing loss, ringing in the ears, vision changes, or neck swelling — this is the combination seen in the published implant cases, where diagnosis was confirmed by serum cobalt levels typically exceeding 30-100 µg/L (PubMed PMID: 41622383), although serum cobalt alone is not reliably predictive of heart damage (PubMed PMID: 27852654).
Hospitals treat as emergencies severe breathlessness at rest, breathing so hard you cannot speak in full sentences, chest pain, fainting or near-fainting, or a racing, pounding, or wildly irregular heartbeat with lightheadedness — these can signal dangerous fluid in the lungs or a serious arrhythmia and are emergencies regardless of the cause. Whether cobalt is involved does not change that; confirming or ruling out a weak heart, and then looking for its cause, is exactly what the evaluation is for.
Key Research Papers
- Morin Y, Bonenfant J, Mercier G, Tetu A (1967). Quebec's beer drinkers myocardosis. The American Journal of Cardiology;19(1):143. — DOI: 10.1016/0002-9149(67)90344-x. — doi:10.1016/0002-9149(67)90344-x
- Morin Y, Daniel P (1967). Quebec beer-drinkers' cardiomyopathy: etiological considerations. Canadian Medical Association Journal;97(15):926-928. — PubMed PMID: 6051264
- Alexander CS (1972). Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. The American Journal of Medicine;53(4):395-417. — DOI: 10.1016/0002-9343(72)90136-2. — doi:10.1016/0002-9343(72)90136-2
- Alexander CS (1969). Cobalt and the Heart. Annals of Internal Medicine;70(2):411-413. — DOI: 10.7326/0003-4819-70-2-411. — doi:10.7326/0003-4819-70-2-411
- Grice HC, Munro IC, Wiberg GS, Heggtveit HA (1969). The Pathology of Experimentally Induced Cobalt Cardiomyopathies. A Comparison with Beer Drinkers' Cardiomyopathy. Clinical Toxicology;2(3):273-287. — DOI: 10.3109/15563656908990934. — doi:10.3109/15563656908990934
- Packer M (2016). Cobalt Cardiomyopathy: A Critical Reappraisal in Light of a Recent Resurgence. Circulation: Heart Failure;9(12):e003604. — DOI: 10.1161/CIRCHEARTFAILURE.116.003604. — doi:10.1161/CIRCHEARTFAILURE.116.003604
- Leyssens L, Vinck B, Van Der Straeten C, Wuyts F, Maes L (2017). Cobalt toxicity in humans — A review of the potential sources and systemic health effects. Toxicology;387:43-56. — DOI: 10.1016/j.tox.2017.05.015. — doi:10.1016/j.tox.2017.05.015
- Paustenbach DJ, Galbraith DA, Finley BL (2013). Interpreting cobalt blood concentrations in hip implant patients. Clinical Toxicology;52(2):98-112. — DOI: 10.3109/15563650.2013.857024. — doi:10.3109/15563650.2013.857024
- Tower SS (2012). Arthroprosthetic cobaltism associated with metal on metal hip implants. BMJ;344:e430. — DOI: 10.1136/bmj.e430. — doi:10.1136/bmj.e430
- Allen LA, Ambardekar AV, Devaraj KM, Maleszewski JJ, Wolfel EE (2014). Missing Elements of the History. New England Journal of Medicine;370(6):559-566. — DOI: 10.1056/NEJMcps1213196. — doi:10.1056/NEJMcps1213196
- Charette RS, Neuwirth AL, Nelson CL (2017). Arthroprosthetic cobaltism associated with cardiomyopathy. Arthroplasty Today;3(4):225-228. — DOI: 10.1016/j.artd.2016.11.005. — doi:10.1016/j.artd.2016.11.005
- Kwon Y-M, Lombardi AV, Jacobs JJ, Fehring TK, Lewis CG, Cabanela ME (2014). Risk Stratification Algorithm for Management of Patients with Metal-on-Metal Hip Arthroplasty: Consensus Statement of the AAOS, AAHKS, and The Hip Society. Journal of Bone and Joint Surgery;96(1):e4. — DOI: 10.2106/jbjs.m.00160. — doi:10.2106/jbjs.m.00160
- Sweeney P, Broderick J (2026). A systematic review and meta-analysis of cases of prosthetic hip-associated cobalt toxicity in patients with prosthetic hip ceramic bearing fractures subsequently revised to metal-on-polyethylene implants. Journal of Orthopaedics;74:113-123. — PubMed PMID: 41550849
- Hullon D, Ahad A, Dabiry SM, Mahindra L (2026). Cobalt-Induced Cardiomyopathy: Mitochondrial Dysfunction, Oxidative Stress, and Reversible Cardiac Toxicity: A Systematic Review. Cardiovascular Toxicology;26(2):24. — PubMed PMID: 41622383
- Vaduganathan M, Docherty KF, Claggett BL, et al. (2022). SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. The Lancet;400(10354):757-767. — PubMed PMID: 36041474